Erysipeloid cutaneous leishmaniasis: a study of 40 cases of an unusual variant.
Journal
International journal of dermatology
ISSN: 1365-4632
Titre abrégé: Int J Dermatol
Pays: England
ID NLM: 0243704
Informations de publication
Date de publication:
Nov 2022
Nov 2022
Historique:
revised:
26
04
2022
received:
18
12
2021
accepted:
28
04
2022
pubmed:
25
5
2022
medline:
19
10
2022
entrez:
24
5
2022
Statut:
ppublish
Résumé
Erysipeloid cutaneous leishmaniasis (ECL) is known as the chronic form of cutaneous leishmaniasis (CL). However, keeping its clinical presentation in view, there is a need to revisit this form of the disease. To describe ECL in view of clinical features and treatment modalities. We include a case series seen in Sfax (Southern Tunisia) from January 2017 to January 2021. All patients clinically suggestive and laboratory confirmed with a diagnosis of CL were registered. Patients of all age groups and of either gender having cutaneous lesions resembling erysipela on the face were included in the study. Different demographic features of the patients and clinical aspects were identified. Descriptive statistics were used for analysis. Of 1300 registered patients with CL, 40 (3%) were diagnosed as ECL. Ages ranged from 15 to 65 years, and duration of lesions varied from 15 to 180 days. All patients had lesions over the face. Clinically, a painful infiltrated inflammatory placard of the central facial area with a butterfly shape was observed in 14 cases, as well as zones of the cheekbone (11 cases), cheekbone and nose (5 cases), cheekbone and eyelid (8 cases), and cheekbone with ear (2 cases). Several therapeutic methods were prescribed with a sufficient result with no recurrence. ECL is a rare presentation that typically occurs on the face, looking like erysipelas, in patients who are native from an endemic region of CL.
Sections du résumé
BACKGROUND
BACKGROUND
Erysipeloid cutaneous leishmaniasis (ECL) is known as the chronic form of cutaneous leishmaniasis (CL). However, keeping its clinical presentation in view, there is a need to revisit this form of the disease.
AIMS
OBJECTIVE
To describe ECL in view of clinical features and treatment modalities.
METHODS
METHODS
We include a case series seen in Sfax (Southern Tunisia) from January 2017 to January 2021. All patients clinically suggestive and laboratory confirmed with a diagnosis of CL were registered. Patients of all age groups and of either gender having cutaneous lesions resembling erysipela on the face were included in the study. Different demographic features of the patients and clinical aspects were identified. Descriptive statistics were used for analysis.
RESULTS
RESULTS
Of 1300 registered patients with CL, 40 (3%) were diagnosed as ECL. Ages ranged from 15 to 65 years, and duration of lesions varied from 15 to 180 days. All patients had lesions over the face. Clinically, a painful infiltrated inflammatory placard of the central facial area with a butterfly shape was observed in 14 cases, as well as zones of the cheekbone (11 cases), cheekbone and nose (5 cases), cheekbone and eyelid (8 cases), and cheekbone with ear (2 cases). Several therapeutic methods were prescribed with a sufficient result with no recurrence.
CONCLUSION
CONCLUSIONS
ECL is a rare presentation that typically occurs on the face, looking like erysipelas, in patients who are native from an endemic region of CL.
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1380-1384Informations de copyright
© 2022 the International Society of Dermatology.
Références
Masmoudi A, Ayadi N, Boudaya S, et al. Polymorphisme clinique de la leishmaniose cutanée du centre et sud tunisien. Bull Soc Pathol Exot 2007; 100: 36-40.
Ceyhan AM, Yildirim M, Basak PY, et al. A case of erysipeloid cutaneous leishmaniasis: atypical and unusual clinical variant. Am J Trop Med Hyg 2008; 78: 406-408.
Qureshi FA, Suliman MI, Sarwar J. Butterfly rash due to cutaneous leishmaniasis. J Coll Physicians Surg Pak 2007; 17: 624-625.
Masmoudi A, Ayadi N, Bouassida S, et al. Anatomo-clinical features of an erysipeloid form of cutaneous leismaniasis in Tunisia. Bull Soc Pathol Exot 2009; 101: 395-397.
Mnejja M, Hammami B, Chakroun A, et al. Unusual form of cutaneous leishmaniasis: erysipeloid form. Eur Ann Otorhinolaryngol Head Neck Dis 2011; 128: 95-97.
Bari AU, Rahman SB. Many faces of cutaneous leishmaniasis. Indian J Dermatol Venereol Leprol 2008; 74: 23-27.
Raja KM, Khan AA, Hameed A, et al. Unusual clinical variants of cutaneous leishmaniasis in Pakistan. Br J Dermatol 1998; 139: 111-113.
Calvopina M, Gomez EA, Uezato H, et al. Atypical clinical variants in New World cutaneous leishmaniasis: disseminated, erysipeloid, and recidiva cutis due to leishmania (V.) panamensis. Am J Trop Med Hyg 2005; 73: 281-284.
El Benaye J, Miloudi M, El Haouri M. Leishmaniose inflammatoire dite « érysipéloïde » de la face. Ann Dermatol Venereol 2015; 142: 379-380.
Özdemır M, Çimen K, Mevlitoğlu İ. Post-traumatic erysipeloid cutaneous leishmaniasis: erysipeloid cutaneous leishmaniasis. Int J Dermatol 2007; 46: 1292-1293.
Kartouti AE, Elbenaye J, Miloudi M. Leishmaniose cutanée érysipéloide: à propos d'une observation clinique. Pan Afr Med J 2015; 21: 54.
Parajuli N, Adhikary S, Karki A, et al. Case report: erysipeloid cutaneous leishmaniasis treated with Oral Miltefosine. Am J Trop Med Hyg 2021; 104: 643-645.
Karincaoglu Y, Esrefoglu M, Ozcan H. Atypical clinical form of cutaneous leishmaniasis: erysipeloid form. Int J Dermatol 2004; 43: 827-829.
Wijesinghe H, Gunathilaka N, Semege S, et al. Histopathology of cutaneous leishmaniasis caused by leishmania donovani in Sri Lanka. Biomed Res Int 2020; 5: e4926819.
Zerehsaz F, Beheshti S, Reza Rezaian G, et al. Erysipeloid cutaneous leishmaniasis: treatment with a new, topical, pure herbal extract. Eur J Dermatol 2003; 13: 145-148.
Nepal S. Case report: an atypical Erysipeloid presentation of cutaneous leishmaniasis from the hilly region of Nepal. Am J Trop Med Hyg 2021; 105: 134-137.